376 related articles for article (PubMed ID: 8377216)
1. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism.
Brilla CG; Matsubara LS; Weber KT
J Mol Cell Cardiol; 1993 May; 25(5):563-75. PubMed ID: 8377216
[TBL] [Abstract][Full Text] [Related]
2. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?].
Brilla CG; Schencking M; Scheer C; Rupp H
Praxis (Bern 1994); 1997 Apr; 86(14):566-74. PubMed ID: 9198851
[TBL] [Abstract][Full Text] [Related]
3. Myocardial fibrosis associated with aldosterone or angiotensin II administration: attenuation by calcium channel blockade.
Ramires FJ; Sun Y; Weber KT
J Mol Cell Cardiol; 1998 Mar; 30(3):475-83. PubMed ID: 9515025
[TBL] [Abstract][Full Text] [Related]
4. Reactive and reparative myocardial fibrosis in arterial hypertension in the rat.
Brilla CG; Weber KT
Cardiovasc Res; 1992 Jul; 26(7):671-7. PubMed ID: 1423431
[TBL] [Abstract][Full Text] [Related]
5. Mineralocorticoid excess, dietary sodium, and myocardial fibrosis.
Brilla CG; Weber KT
J Lab Clin Med; 1992 Dec; 120(6):893-901. PubMed ID: 1453111
[TBL] [Abstract][Full Text] [Related]
6. Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension.
Brilla CG; Matsubara LS; Weber KT
Am J Cardiol; 1993 Jan; 71(3):12A-16A. PubMed ID: 8421998
[TBL] [Abstract][Full Text] [Related]
7. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone.
Brilla CG; Zhou G; Matsubara L; Weber KT
J Mol Cell Cardiol; 1994 Jul; 26(7):809-20. PubMed ID: 7966349
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme and myocardial fibrosis in the rat receiving angiotensin II or aldosterone.
Sun Y; Ratajska A; Zhou G; Weber KT
J Lab Clin Med; 1993 Oct; 122(4):395-403. PubMed ID: 8228553
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone and myocardial fibrosis in heart failure.
Brilla CG
Herz; 2000 May; 25(3):299-306. PubMed ID: 10904856
[TBL] [Abstract][Full Text] [Related]
10. Mineralocorticoids, hypertension, and cardiac fibrosis.
Young M; Fullerton M; Dilley R; Funder J
J Clin Invest; 1994 Jun; 93(6):2578-83. PubMed ID: 8200995
[TBL] [Abstract][Full Text] [Related]
11. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.
Neves MF; Amiri F; Virdis A; Diep QN; Schiffrin EL;
Can J Physiol Pharmacol; 2005 Nov; 83(11):999-1006. PubMed ID: 16391708
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis, myocardial fibrosis and angiotensin II in the left ventricle of hypertensive rats treated with fosinopril or losartan.
Yu G; Liang X; Xie X; Yang T; Sun M; Zhao S
Chin Med J (Engl); 2002 Sep; 115(9):1287-91. PubMed ID: 12411096
[TBL] [Abstract][Full Text] [Related]
13. Effects of ACE inhibition versus non-ACE inhibitor antihypertensive treatment on myocardial fibrosis in patients with arterial hypertension. Retrospective analysis of 120 patients with left ventricular endomyocardial biopsies.
Brilla CG; Rupp H; Maisch B
Herz; 2003 Dec; 28(8):744-53. PubMed ID: 14689110
[TBL] [Abstract][Full Text] [Related]
14. Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone.
Paulis L; Matuskova J; Adamcova M; Pelouch V; Simko J; Krajcirovicova K; Potacova A; Hulin I; Janega P; Pechanova O; Simko F
Acta Physiol (Oxf); 2008 Sep; 194(1):45-55. PubMed ID: 18419778
[TBL] [Abstract][Full Text] [Related]
15. Heart remodeling in the hereditary hypertriglyceridemic rat: effect of captopril and nitric oxide deficiency.
Simko F; Luptak I; Matuskova J; Babal P; Pechanova O; Bernatova I; Hulin I
Ann N Y Acad Sci; 2002 Jun; 967():454-62. PubMed ID: 12079874
[TBL] [Abstract][Full Text] [Related]
16. A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone.
López-Andrés N; Martin-Fernandez B; Rossignol P; Zannad F; Lahera V; Fortuno MA; Cachofeiro V; Díez J
Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2372-82. PubMed ID: 21926338
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II-induced myocardial fibrosis in rats: role of nitric oxide, prostaglandins and bradykinin.
Sigusch HH; Campbell SE; Weber KT
Cardiovasc Res; 1996 Apr; 31(4):546-54. PubMed ID: 8689646
[TBL] [Abstract][Full Text] [Related]
18. Myocardial fibrosis rather than hypertrophy induces diastolic dysfunction in renovascular hypertensive rats.
Matsubara LS; Matsubara BB; Okoshi MP; Franco M; Cicogna AC
Can J Physiol Pharmacol; 1997 Dec; 75(12):1328-34. PubMed ID: 9534942
[TBL] [Abstract][Full Text] [Related]
19. Regression of myocardial fibrosis in hypertensive heart disease: diverse effects of various antihypertensive drugs.
Brilla CG
Cardiovasc Res; 2000 May; 46(2):324-31. PubMed ID: 10773237
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of angiotensin II receptor blockade on pressure-induced left ventricular hypertrophy and fibrosis in rats.
Baba HA; Iwai T; Bauer M; Irlbeck M; Schmid KW; Zimmer HG
J Mol Cell Cardiol; 1999 Feb; 31(2):445-55. PubMed ID: 10093056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
